Enavatuzumab is a humanized monoclonal antibody used in the treatment of solid tumors.
Enavatuzumab was developed by Facet Biotech Corp.
The source of this article is
wikipedia, the free encyclopedia. The text of this article is licensed under the
GFDL.
